Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
2.950
+0.030 (1.03%)
Sep 3, 2026, 4:00 PM EDT - Market closed
Entera Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| - | 0.04 | 0.18 | - | 0.13 | 0.57 | |
Revenue Growth | - | -76.80% | - | - | -76.53% | 56.44% |
Cost of Revenue | - | 0.04 | 0.17 | - | 0.1 | 0.37 |
Gross Profit | - | - | 0.01 | - | 0.03 | 0.2 |
Selling, General & Admin | 5.59 | 5.53 | 5.1 | 4.43 | 7.71 | 5.69 |
Research & Development | 8.81 | 6 | 4.5 | 4.51 | 5.85 | 6.77 |
Other Operating Expenses | - | - | - | -0.05 | -0.05 | -0.05 |
Operating Expenses | 14.4 | 11.53 | 9.59 | 8.89 | 13.51 | 12.42 |
Operating Income | -14.4 | -11.53 | -9.59 | -8.89 | -13.47 | -12.22 |
Interest Expense | -2.72 | - | - | - | - | - |
Interest & Investment Income | 0.08 | 0.09 | 0.06 | 0.03 | - | - |
Currency Exchange Gain (Loss) | - | - | - | - | - | -0.03 |
Other Non Operating Income (Expenses) | - | - | - | - | 0.08 | - |
EBT Excluding Unusual Items | -17.03 | -11.44 | -9.53 | -8.86 | -13.39 | -12.25 |
Other Unusual Items | - | - | - | - | 0.46 | - |
Pretax Income | -17.03 | -11.44 | -9.53 | -8.86 | -12.93 | -12.25 |
Income Tax Expense | - | - | 0.01 | 0.03 | 0.14 | -0.06 |
Net Income | -17.03 | -11.44 | -9.54 | -8.89 | -13.07 | -12.19 |
Net Income to Common | -17.03 | -11.44 | -9.54 | -8.89 | -13.07 | -12.19 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 48 | 46 | 38 | 29 | 29 | 26 |
Shares Outstanding (Diluted) | 48 | 46 | 38 | 29 | 29 | 26 |
Shares Change | 15.32% | 22.68% | 29.79% | 0.69% | 10.23% | 41.90% |
EPS (Basic) | -0.35 | -0.25 | -0.25 | -0.31 | -0.45 | -0.47 |
EPS (Diluted) | -0.35 | -0.25 | -0.25 | -0.31 | -0.45 | -0.47 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -10.96 | -7.48 | -6.82 | -7.33 | -12.55 | -9.08 |
Free Cash Flow Per Share | -0.23 | -0.16 | -0.18 | -0.25 | -0.44 | -0.35 |
Gross Margin | - | - | 4.97% | - | 24.63% | 34.68% |
Operating Margin | - | -27450.00% | -5295.58% | - | -10055.22% | -2139.58% |
Profit Margin | - | -27235.71% | -5271.27% | - | -9754.48% | -2134.33% |
Free Cash Flow Margin | - | -17802.38% | -3768.51% | - | -9362.69% | -1590.19% |
EBITDA | -14.37 | -11.5 | -9.54 | -8.84 | -13.41 | -12.16 |
D&A For EBITDA | 0.03 | 0.03 | 0.05 | 0.06 | 0.06 | 0.05 |
EBIT | -14.4 | -11.53 | -9.59 | -8.89 | -13.47 | -12.22 |